Ravi A Madan Selected Research

Ravi A Madan Research Topics

Disease

114	Prostatic Neoplasms (Prostate Cancer) 05/2024 - 01/2006
86	Neoplasms (Cancer) 10/2023 - 04/2006
15	Disease Progression 10/2023 - 01/2007
12	Carcinoma (Carcinomatosis) 01/2020 - 01/2007
10	Neoplasm Metastasis (Metastasis) 05/2024 - 07/2008
10	Vaccinia 05/2023 - 04/2007
5	Fowlpox 05/2023 - 04/2007
5	Melanoma (Melanoma, Malignant) 01/2019 - 12/2010
4	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 10/2015
4	Chordoma 01/2021 - 11/2015
4	Renal Cell Carcinoma (Grawitz Tumor) 01/2020 - 12/2014
4	Urinary Bladder Neoplasms (Bladder Cancer) 01/2020 - 08/2014
3	Injection Site Reaction 01/2023 - 03/2014
3	Human Influenza (Influenza) 01/2021 - 02/2014
3	Fatigue 01/2021 - 06/2013
3	medullary Thyroid cancer 01/2020 - 08/2014
3	Urogenital Neoplasms 01/2020 - 01/2020
3	Breast Neoplasms (Breast Cancer) 08/2016 - 11/2015
2	Necrosis 01/2023 - 01/2019
2	Sarcoma (Soft Tissue Sarcoma) 01/2021 - 08/2014
2	Hypothyroidism 01/2020 - 08/2014
2	Thyroiditis 01/2020 - 08/2014
2	Colitis 01/2018 - 05/2012
2	Ovarian Neoplasms (Ovarian Cancer) 08/2014 - 11/2011
1	Asymptomatic Diseases 05/2024
1	Adenocarcinoma 01/2023
1	Lymphopenia (Lymphocytopenia) 01/2023
1	Microsatellite Instability 01/2023
1	Bites and Stings (Sting) 01/2023

Drug/Important Bio-Agent (IBA)

56	VaccinesIBA 05/2023 - 04/2006
28	Cancer VaccinesIBA 01/2023 - 04/2007
26	AntigensIBA 03/2024 - 01/2007
22	PROSTVACIBA 10/2023 - 07/2009
19	sipuleucel-T (APC8015)FDA Link 01/2023 - 01/2010
19	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2013
15	AndrogensIBA 05/2024 - 05/2007
15	Prostate-Specific Antigen (Semenogelase)IBA 05/2023 - 04/2006
13	Docetaxel (Taxotere)FDA Link 01/2023 - 01/2010
10	IpilimumabIBA 01/2019 - 05/2012
9	enzalutamideIBA 05/2024 - 08/2013
8	Brachyury protein (Brachyury)IBA 01/2021 - 10/2015
7	CytokinesIBA 10/2022 - 02/2009
6	Androgen Receptors (Androgen Receptor)IBA 05/2024 - 03/2010
6	avelumabIBA 01/2023 - 01/2017
6	Monoclonal AntibodiesIBA 01/2023 - 09/2007
6	Biomarkers (Surrogate Marker)IBA 11/2022 - 11/2012
6	Proteins (Proteins, Gene)FDA Link 12/2020 - 09/2011
5	Hormones (Hormone)IBA 01/2023 - 01/2007
5	Transcription Factors (Transcription Factor)IBA 01/2021 - 11/2015
5	Prednisone (Sone)FDA LinkGeneric 01/2021 - 04/2010
4	FluoridesIBA 10/2023 - 11/2018
4	Poly(ADP-ribose) Polymerase InhibitorsIBA 10/2023 - 12/2018
4	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 01/2019
4	LigandsIBA 12/2020 - 10/2012
4	Carcinoembryonic AntigenIBA 11/2015 - 04/2007
3	Interleukin-12 (IL 12)IBA 01/2023 - 01/2019
3	prostatic acid phosphataseIBA 01/2023 - 01/2017
3	pembrolizumabIBA 01/2023 - 01/2017
3	Interleukin-8 (Interleukin 8)IBA 10/2022 - 01/2019
3	Transforming Growth Factors (Transforming Growth Factor)IBA 10/2022 - 01/2019
3	CamptothecinIBA 01/2022 - 03/2020
3	IT-101IBA 01/2022 - 03/2020
3	olaparibIBA 12/2021 - 12/2018
3	smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordicIBA 01/2021 - 08/2019
3	abirateroneIBA 01/2018 - 01/2006
3	Peptides (Polypeptides)IBA 08/2016 - 04/2006
2	Amylases FDA Link 01/2023 - 01/2017
2	Histones (Histone)IBA 01/2023 - 01/2019
2	Lipase (Acid Lipase)FDA Link 01/2023 - 01/2018
2	cabazitaxel FDA Link 01/2023 - 06/2011
2	Testosterone (Sustanon)FDA Link 01/2022 - 01/2021
2	durvalumabIBA 12/2021 - 12/2018
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 10/2021 - 06/2013
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2021 - 01/2010
2	Phosphotransferases (Kinase)IBA 10/2021 - 06/2013
2	cabozantinibIBA 01/2021 - 08/2014
2	Immunoglobulin G (IgG)IBA 12/2020 - 01/2017
2	Tyrosine Kinase InhibitorsIBA 01/2020 - 12/2014
2	AntibodiesIBA 01/2020 - 10/2019
2	B7-H1 AntigenIBA 10/2019 - 01/2018
2	B7 AntigensIBA 08/2019 - 11/2017
2	NivolumabIBA 01/2019 - 01/2017
2	EndoglinIBA 01/2017 - 10/2015
2	carotuximabIBA 01/2017 - 10/2015
2	Neoplasm Antigens (Tumor Antigens)IBA 01/2017 - 06/2016
2	Bevacizumab (Avastin)FDA Link 10/2016 - 04/2010
2	Immunomodulating AgentsIBA 05/2016 - 02/2013
1	rucaparibIBA 01/2024
1	mesoglycanIBA 10/2023
1	Flutamide (Eulexin)FDA LinkGeneric 01/2023
1	Chimeric Antigen ReceptorsIBA 01/2023
1	Recombinant Fusion ProteinsIBA 01/2023
1	LutetiumIBA 01/2023
1	RadiumIBA 01/2023

Therapy/Procedure

66	Therapeutics 05/2024 - 01/2003
46	Castration 03/2024 - 07/2008
41	Immunotherapy 10/2023 - 12/2008
17	Drug Therapy (Chemotherapy) 01/2021 - 01/2007
8	Radiotherapy 01/2021 - 01/2007
5	Prostatectomy (Retropubic Prostatectomy) 01/2022 - 01/2017